Eyenuk vs Overjet
Overjet's earliest FDA record is Dental Assist (K210187, May 19, 2021). The newest is Multi-Image Caries and Charting Assist (K261059, August 6, 2026). Iris (K253930, April 10, 2026) is web-based dental imaging software rather than a detection tool, and CBCT Assist (K251514) was decided on December 5, 2025. Overjet's Trust Center page says it completed an independent HITRUST audit, and the company announced a $53.2 million Series C in March 2024. A 2026 Journal of Dentistry study set bitewings, ICDAS visual scoring and Overjet Caries Assist against micro-CT, and AI sensitivity at the dentin threshold was 56% against 75% for bitewings and 100% for ICDAS, while a 2025 Frontiers in Dental Medicine paper reported 0.91 dentin sensitivity for the same tool.
Overjet is sold to dentists and DSOs for chairside films, and the health systems Eyenuk names as customers use EyeArt on retinal photographs of diabetic patients. Eyenuk's openFDA entries are K200667 (EyeArt, August 3, 2020) and K223357 (EyeArt v2.2.0, June 16, 2023), and the vendor names Temple Health, Nebraska Medicine and University of Kentucky HealthCare as customers.
Radiology · Reviewed November 2, 2026
When to pick each one
Eyenuk
- The vendor names Temple Health and Nebraska Medicine
- EyeArt K200667, August 3, 2020 on openFDA
Overjet
- Caries, calculus and periapical radiolucency detection
- CBCT Assist K251514, December 5, 2025
- Trust Center page says an independent HITRUST audit was completed
Score
Each row shows points earned of points available under the published rubric.
Eyenuk
71of 100
Overjet
42of 100
| Dimension | Eyenuk | Overjet | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 10 / 10 | 0 / 10 | +10 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 18.2 / 18.2 | 0 / 18.2 | +18.2 |
| RCT / meta-analysis / systematic review | 7.8 / 7.8 | 0 / 7.8 | +7.8 |
| Funding & adoption signal | 3 / 12 | 8.4 / 12 | -5.4 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 6 / 6 | -6 |
Scroll horizontally to see every column.
Pricing
Eyenuk
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Overjet
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Eyenuk
FDA decisions
K223357 (opens in new tab)510(k)2023-06-16
EyeArt v2.2.0
K200667 (opens in new tab)510(k)2020-08-03
EyeArt
Peer-reviewed
5 PubMed records name Eyenuk.
- Diagnostic Accuracy of the EyeArt Artificial Intelligence System for Diabetic Retinopathy: A Systematic Review and Meta-Analysis. (opens in new tab)
- A pilot cost-analysis study comparing AI-based EyeArt® and ophthalmologist assessment of diabetic retinopathy in minority women in Oslo, Norway. (opens in new tab)
- [Use of Artificial Intelligence in Diabetic Retinopathy Screening: Experience in a Health Service in Santiago, Chile]. (opens in new tab)
Overjet
FDA decisions
K261059 (opens in new tab)510(k)2026-08-06
Overjet Multi-Image Caries and Charting Assist
K251514 (opens in new tab)510(k)2025-12-05
Overjet CBCT Assist
K241681 (opens in new tab)510(k)2024-09-09
Overjet Image Enhancement Assist
K241684 (opens in new tab)510(k)2024-08-27
Overjet Charting Assist (updated)
K233738 (opens in new tab)510(k)2024-03-04
Overjet Caries Assist-Pediatric
Show 6 more
K233590 (opens in new tab)510(k)2024-02-23
Overjet Charting Assist
K231678 (opens in new tab)510(k)2023-09-21
Overjet Periapical Radiolucency Assist
K222746 (opens in new tab)510(k)2023-03-27
Overjet Caries Assist
K220928 (opens in new tab)510(k)2022-12-16
Overjet Calculus Assist
K212519 (opens in new tab)510(k)2022-05-10
Overjet Caries Assist
K210187 (opens in new tab)510(k)2021-05-19
Overjet Dental Assist
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Eyenuk | Overjet |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | 2018 |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.